NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Parkinson's disease (PD) is the second most common neurodegenerative disorder, and its rising incidence poses a growing burden on productivity and healthcare systems, particularly in the context of global population aging. Despite substantial advances in research, the pathogenesis of PD remains incompletely understood, and no curative or effective preventive therapies are currently available. Emerging evidence suggests a potential link between fatty acid (FA) metabolism and PD pathogenesis, positioning the modulation of FA metabolic pathways as a promising therapeutic strategy. This review examines the interplay between FA metabolism and key pathological processes, including oxidative stress, neuroinflammation, and the abnormal aggregation of alpha-synuclein, within the context of PD. By integrating these perspectives, the article aims to advance understanding of disease mechanisms and identify novel opportunities for prevention, early diagnosis, and targeted treatment.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.